# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Eyenovia shares are surging Monday in response to the company's announcement of the launch of a new FDA-approved ophthalmic...
Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shi...
- Form 4
Eyenovia (stock surges with high trading volume after announcing a $5.14 million offering to fund commercialization of Mydcombi...
Eyenovia shares are trading lower by 35% Wednesday morning. The company announced plans to sell shares or pre-funded warrants i...